Free Trial

Eagle Pharmaceuticals (EGRX) SEC Filings & 10K Form

Eagle Pharmaceuticals logo
$1.50 -0.05 (-3.23%)
As of 03:50 PM Eastern

Recent Eagle Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/19/2025
3:32 PM
Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
02/19/2025
3:32 PM
Eagle Pharmaceuticals (Subject)
Nantahala Capital Partners Limited Partnership (Filed by)
Form SCHEDULE 13G
02/14/2025
8:01 AM
Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
12/09/2024
11:15 PM
Eagle Pharmaceuticals (Filer)
Form EFFECT
12/02/2024
3:17 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:05 PM
Eagle Pharmaceuticals (Filer)
Form S-8 POS
11/27/2024
3:06 PM
Eagle Pharmaceuticals (Filer)
Form S-8 POS
11/27/2024
3:06 PM
Eagle Pharmaceuticals (Filer)
Form S-8 POS
11/27/2024
3:07 PM
Eagle Pharmaceuticals (Filer)
Form S-8 POS
11/27/2024
3:07 PM
Eagle Pharmaceuticals (Filer)
Form S-8 POS
11/27/2024
3:07 PM
Eagle Pharmaceuticals (Filer)
Form S-8 POS
11/27/2024
3:08 PM
Eagle Pharmaceuticals (Filer)
Form POS AM
11/27/2024
3:08 PM
Eagle Pharmaceuticals (Filer)
Form RW
11/27/2024
8:25 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2024
6:59 PM
Eagle Pharmaceuticals (Issuer)
Krawtschuk Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/15/2024
4:19 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
10:34 AM
BRANDES INVESTMENT PARTNERS, LP (Filed by)
Eagle Pharmaceuticals (Subject)
Form SC 13G/A
11/14/2024
9:25 AM
Eagle Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/13/2024
7:30 AM
Eagle Pharmaceuticals (Filer)
Form NT 10-Q
11/12/2024
6:08 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:32 PM
Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13G/A
10/31/2024
12:36 PM
Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
Form SC 13G/A
10/31/2024
7:50 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
3:05 PM
Eagle Pharmaceuticals (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G/A
10/08/2024
11:42 AM
Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
Form SC 13G
10/02/2024
8:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:30 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:35 PM
Eagle Pharmaceuticals (Filer)
Form NT 10-Q
08/05/2024
8:03 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
7:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Eagle Pharmaceuticals (Subject)
Form SC 13G/A
07/03/2024
1:02 PM
Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13G
05/29/2024
7:20 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
8:08 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
8:29 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
4:27 PM
Eagle Pharmaceuticals (Filer)
Form NT 10-Q
04/12/2024
3:16 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:16 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:EGRX) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners